The Making of a Molecule: Peptide Synthesis 
By

By
The success of the GLP-1 agonists and related follow-on drugs has renewed interest in peptide-based drugs. Industry experts share their perspectives on the latest in peptide synthesis. 

FDA Launches 1-Day Inspections Pilot
By

By
As part of a broader initiative to make its inspectional resources efficient, FDA has launched a pilot for one-day inspectional assessments. What does the new program involve?

Manufacturing Insights: Novartis’ Next Move
By

By
Novartis announced this week another leg in its $23-billion US capital investment plan—a new API manufacturing facility in North Carolina. Is the company’s manufacturing strategy aligning with its overall growth strategy?

Finding a Niche: Rare-Disease Drugs & Deal-Making
By

By
Are rare-disease drugs still factoring into the growth strategies of the pharmaceutical majors? Which recent deals stand out? DCAT Value Chain Insights takes an inside look at the companies, products, and deals. 

Sanofi’s New CEO Taking the Helm: What Will Be the Growth Strategy?
By

By
Merck KGaA Chair and CEO Belén Garijo is coming on board as Sanofi’s new CEO next week, succeeding former CEO Paul Hudson, who stepped down in February. The company reported its first quarter results this week? What products—commercial and pipeline will drive growth?

Europe & Biomanufacturing: Boosting Capacity & Innovation
By

By
Almost 40 European, national, and regional industry organizations have signed a joint position paper to support the European Union’s Biotech Act II, an initiative to boost capacity and innovation in biomanufacturing in the EU. What does it mean for the bio/pharma industry?

AI: The Marriage of High Tech & Big Pharma
By

By
Novo Nordisk is the latest pharmaceutical major to partner directly with a high-tech giant to advance AI in their operations, including for drug development, manufacturing, and the supply chain. A roundup of the latest partnerships and projects.

Mastering the Supply Chain, Digitalization & Global Shifts
By

By
An upcoming DCAT conference, The DCAT Global Summit 2026: The Future of Bio/Pharma: Mastering the Supply Chain, Digitalization & Global Shifts, June 10-11, in Sitges, Barcelona, Spain, will provide executive perspectives on AI and digital transformation across the bio/pharmaceutical value chain.

CEOs, Senior Executives Highlight Expansions at the DCAT Member Company Announcement Forum
By

By
CEOs and senior executives from DCAT Member Companies highlighted their companies’ major news at the DCAT Member Company Announcement Forum at DCAT Week.

DCAT Value Chain Insights Bonus Coverage: From DCAT Week 2026 Member Company News Roundup 
By

By
What other DCAT Member Companies are making news from DCAT Week? A roundup of the latest developments from suppliers and CDMOs/CMOs.